A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Trial details
- Registry ID
- NCT06092034
- Phase
- Phase 2
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseNCT06092034 | RCKT | Phase 2 | Recruiting | 2028-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |